Jeffrey Jonas Selected Research

zuranolone

1/2022	Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.
1/2022	A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.
1/2021	Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
1/2021	Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder.
1/2019	Trial of SAGE-217 in Patients with Major Depressive Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey Jonas Research Topics

Disease

4	Headache (Headaches) 01/2022 - 03/2006
4	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 03/2006
3	Postpartum Depression (Post-Natal Depression) 01/2021 - 01/2017
3	Sleepiness 01/2019 - 01/2017
3	Dizziness (Lightheadedness) 01/2019 - 01/2017
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2017
1	Fatigue 01/2022
1	Pancreatitis 01/2021
1	Confusion (Bewilderment) 01/2021
1	Nausea 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2018
1	Sinus Tachycardia 01/2017
1	Pain (Aches) 01/2017
1	Tension-Type Headache (Tension Headache) 01/2017
1	Mood Disorders (Mood Disorder) 01/2017
1	Binge-Eating Disorder (Binge Eating Disorder) 03/2015
1	Obesity 03/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2015
1	Abdominal Pain (Pain, Abdominal) 03/2006

Drug/Important Bio-Agent (IBA)

5	zuranoloneIBA 01/2022 - 01/2019
2	Pregnanolone (Allopregnanolone)IBA 01/2018 - 01/2017
2	brexanoloneIBA 01/2018 - 01/2017
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2018 - 01/2017
1	Tuberculin (PPD)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Progesterone FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Hormones (Hormone)IBA 01/2017
1	Lisdexamfetamine Dimesylate FDA Link 03/2015
1	Escitalopram FDA Link 03/2006

Therapy/Procedure

1	Therapeutics 01/2017
1	Drug Therapy (Chemotherapy) 03/2015